<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-058111</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prognostic value of ECGs in patients with type-2 diabetes mellitus without known cardiovascular disease</dc:title>
<dc:description xml:lang="en">Introduction and objectives. The predictive value of ECG abnormalities in patients with type-2 diabetes mellitus (DM2) has not been fully studied. Our objective was to assess the prognostic value of ECG abnormalities in patients with DM2 but without known cardiovascular disease. Methods. Overall, 412 patients with DM2 were identified at two primary care centers in the same city. Two hundred and tiwenty one patients younger 80 years without known cardiovascular disease were included in the study. An ECG was recorded at baseline and annually during follow-up. The ECGs were evaluated using a system based on the Minnesota code. The main study end-point during follow-up was the occurrence of a cardiovascular event, as defined in the Framingham study. Results. The mean follow-up duration was 5.9 years (1.1­8.5 years). At the beginning of the study, 24.9% of patients had ECG abnormalities; at the end, 44.3% had abnormalities. Cardiovascular events occurred in 65 patients (29.4%). The relative risk (RR) of a cardiovascular event in a patient with an ECG abnormality was 8.28 (95% confidence interval [CI], 3.36­20.42). Only hypertension (RR = 2.29; 95% CI, 1.24­4.22) and age were significantly related to the occurrence of a cardiovascular event. Multiple regression analysis that included classical risk factors and ECG findings showed that an ECG abnormality was a significant independent predictor, with adjusted RR = 5.95 (95% CI, 2.29­15.47). Conclusions. The presence of an ECG abnormality can predict the occurrence of a future cardiovascular event in patients with DM2 more accurately than risk factors alone. This finding could be helpful in selecting subgroups of high-risk diabetic patients (AU)</dc:description>
<dc:creator>Santiago, Ana de</dc:creator>
<dc:creator>Santiago, Catalina</dc:creator>
<dc:creator>García-Lledó, Alberto</dc:creator>
<dc:creator>Ramos, Esther</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y objetivos. El valor predictivo de las alteraciones del electrocardiograma no ha sido plenamente estudiado en la diabetes tipo 2 (DM2). Nuestro objetivo fue evaluar el valor pronóstico de las alteraciones del ECG en pacientes con DM2 sin enfermedad cardiovascular conocida.  Métodos. Se identificó 412 casos de DM2 en dos centros de salud de una misma población. Se incluyó en el estudio a 221, menores de 80 años sin enfermedad cardiovascular conocida. Se realizó un seguimiento con un ECG anual. Se analizaron los ECG mediante un sistema basado en el código de Minnesota. Se consideró puntos finales del seguimiento los eventos cardiovasculares definidos en el estudio de Framingham.  Resultados. El seguimiento medio (intervalo) fue de 5,9 (1,1-8,5) años. El 24,9% de los pacientes mostraba alteraciones en el ECG al inicio del estudio y el 44,3%, al final. Hubo eventos en 65 (29,4%) casos. El riesgo relativo (RR) de tener un evento con ECG anormal era de 8,28 (intervalo de confianza [IC] del 95%, 3,36-20,42). Sólo la hipertensión (RR = 2,29; IC del 95%, 1,24-4,22) y la edad mostraron relación significativa con los eventos. Un estudio de regresión múltiple que incluía los factores de riesgo clásicos y el ECG mostró que éste tenía un valor predictivo independiente, con RR ajustado = 5,95 (IC del 95%, 2,29-15,47).  Conclusiones. Las alteraciones del ECG pueden predecir la aparición de eventos cardiovasculares con mayor precisión que los factores de riesgo solos en los pacientes con DM2. Esto podría ser de interés para seleccionar subpoblaciones de diabéticos de mayor riesgo (AU)</dc:description>
<dc:source>Rev Esp Cardiol;60(10): 1035-1041, oct. 2007. ilus, tab</dc:source>
<dc:identifier>ibc-058111</dc:identifier>
<dc:title xml:lang="es">Valor pronóstico del electrocardiograma en pacientes con diabetes tipo 2 sin enfermedad cardiovascular conocida</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d3946^s22012</dc:subject>
<dc:subject>^d4634^s22045</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28606</dc:subject>
<dc:subject>^d24584</dc:subject>
<dc:subject>^d2359^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>200710</dc:date>
</metadata>
</record>
</ibecs-document>
